BSX - Comprehensive Filing Intelligence

FY•10-K•Filed Feb 17, 2026
4.0/10
Filing Health:CAUTION

Notable concerns that warrant closer review

Executive Summary

The company faces significant legal risks with limited insurance coverage for key liabilities like product liability and environmental claims.. Reorganization of operating segments in Q4 2025 with no impact on reportable segments.

Top Concerns

  • !Large increases in goodwill and intangible assets due to recent acquisitions.
  • !The company faces significant legal risks with limited insurance coverage for key liabilities like product liability and environmental claims.
  • !Adverse outcomes in ongoing litigation could materially impact the company's financial position, operations, and liquidity.
  • !Competitive and Technological Disruption (high)
  • !Cybersecurity Threats and Data Integrity (high)

Top Positives

  • +Management characterizes liquidity as strong, with sufficient cash and credit facilities to cover operational needs and planned acquisitions for the foreseeable future.
  • +The company is actively pursuing strategic growth through significant acquisitions, including Nalu Medical and Penumbra, Inc., with the latter representing a substantial investment.
  • +While reporting strong commercial execution, management expresses caution regarding macroeconomic uncertainties such as inflation, interest rates, and global trade policies.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

5.0/10

Management tone is balanced.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

7.0/10

Earnings quality shows moderate accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is elevated.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

3.0/10

Overall risk profile shows competitive and technological disruption as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

7.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.

Related Research

Analysis

EW 10-K Analysis: $534M Charge Year Masks a 60% Margin Machine

Analysis

BSX 10-K Analysis: ROIC Inflection Meets the $14.5B Penumbra Gamble

Analysis

Medical Device ROIC Rankings: Why Abbott's 26% Beats Medtronic's 7% (The Gross Margin Paradox)